Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2368

Feb 16, 2018

CRISPR Isn’t Just for Gene Editing Anymore

Posted by in categories: bioengineering, biotech/medical, genetics

A scientist cuts a DNA fragment under UV light for DNA sequencing. Image: AP Five years ago, when researchers first discovered that bacterial immune systems could be hijacked to edit DNA in living creatures, it was big news. The technology, called CRISPR, allowed scientists to more easily than ever cut and paste all those As, Cs, Ts, and Gs that make up the base pairs of DNA and encode the world’s living things. With CRISPR, scientists could use genetic engineering to tackle problems from disease to famine. But gene editing with CRISPR is so 2017. Recently, scientists have begun exploring n…

Read more

Feb 16, 2018

Fragile X syndrome neurons can be restored, study shows

Posted by in categories: biotech/medical, genetics, neuroscience

New Whitehead Institute research may prove to be a useful paradigm for targeting diseases caused by abnormal methylation. Credit: Steven Lee/Whitehead Institute Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting one out of every 3,600 boys born. The syndrome can also cause autistic traits, such as social and communication deficits, as well as attention problems and hyperactivity. Currently, there is no cure for this disorder. Fragile X syndrome is caused by mutations in the FMR1 gene on the X chromosome, which prevent the gene’s expression. This abs…

Read more

Feb 16, 2018

CRISPR-Cas9 may be a double-edged sword for bacteria

Posted by in category: biotech/medical

CRISPR-associated protein Cas9 (white) from Staphylococcus aureus based on Protein Database ID 5AXW. Credit: Thomas Splettstoesser (Wikipedia, CC BY-SA 4.0) A team of researchers with the Catholic University of America has found evidence that suggests a defense mechanism used by bacteria to ward off phage attacks might also be benefiting the phages. In their paper published on the open access site Science Advances, the group describes testing the impact of CRISPR-Cas9 on phages that infect Escherichia coli and what they found. In nature, CRISPR-Cas9 is a defense mechanism used by bacteria t…

Read more

Feb 16, 2018

Lab-grown human cerebellar cells yield clues to autism

Posted by in categories: biotech/medical, neuroscience

This Purkinje neuron was derived from patients with tuberous sclerosis and model properties of the disease at the cellular and molecular level. Sundberg and colleagues first created induced pluripotent stem cells (iPSCs) from patients’ blood cells or skin cells, then differentiated them into neural progenitor cells and finally Purkinje cells. Credit: Courtesy Maria Sundberg, PhD, Sahin Laboratory, Boston Children’s Hospital Increasing evidence has linked autism spectrum disorder (ASD) with dysfunction of the brain’s cerebellum, but the details have been unclear. In a new study, researchers…

Read more

Feb 16, 2018

Forever Young: The Documentary — BBC News

Posted by in categories: biotech/medical, education, life extension

Is ageing a disease? One that can be ‘cured’? BBC’s Gabriela Torres meets the self-experimenters and scientists who are trying to dramatically extend our lives.

Please subscribe HERE http://bit.ly/1rbfUog

Continue reading “Forever Young: The Documentary — BBC News” »

Feb 15, 2018

Removing One Enzyme Could Be Key to Curing Alzheimer’s

Posted by in categories: biotech/medical, neuroscience

An experimental treatment completely reversed Alzheimer’s disease in mice by reducing the levels of a single enzyme in the animals’ brains. The results further bolster the theory that amyloid plaques are at the root of this mysterious brain disease, and that addressing these plaques could lead to an eventual cure for Alzheimer’s. The study, published February 14 in the Journal of Experimental Medicine, found that slowly reducing levels of the enzyme BACE1 in mice as they aged either prevented or reversed the formation of amyloid plaques in the brain, a hallmark sign of Alzheimer’s disease…

Read more

Feb 15, 2018

Undoing Aging Conference – Berlin 2018

Posted by in categories: biotech/medical, life extension

The Undoing Aging 2018 Conference is coming to Berlin to discuss the science of rejuvenation biotech!


The SENS Research Foundation and the Forever Healthy Foundation have joined forces to host an exciting conference about rejuvenation biotechnology on March 15–17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany.

A conference for everyone

Continue reading “Undoing Aging Conference – Berlin 2018” »

Feb 15, 2018

China announces world’s first lung regenerative therapy

Posted by in categories: biotech/medical, innovation

Tongji University has announced what it says is a major breakthrough in the treatment of lung disease by repairing tissue through stem cell transplantation.

Read more

Feb 14, 2018

Want to Lose Weight? Here’s How To Get 10 Servings Of Fruit And Vegetables Daily

Posted by in categories: biotech/medical, food, life extension

Summary: Practical tips on how to consume 10 servings of fruits and vegetables daily to lose weight and improve health. [This article first appeared on the LongevityFacts website. Author: Brady Hartman.]

Fruits and vegetables are rich in phytonutrients and are an integral part of the healthiest diet plans. Here are practical tips on how to incorporate more plant foods into your meals.

Due to a poor diet, about half of all American adults have one or more preventable chronic diseases, including type 2 diabetes, overweight, obesity or cardiovascular disease. A large body of evidence, including newly published research on the health benefits of fruit and vegetables, shows that increased consumption of whole plant foods is linked to reduced risk of death and chronic diseases.

Continue reading “Want to Lose Weight? Here’s How To Get 10 Servings Of Fruit And Vegetables Daily” »

Feb 14, 2018

Trial Shows Canakinumab Prevents Cancer and Heart Attacks

Posted by in category: biotech/medical

Doctors implicate chronic inflammation as a cause of heart disease and cancer with some claiming that reducing persistent, low-grade inflammation will reduce these diseases. In fact, a recent clinical trial discovered that the inflammation-lowering drug Canakinumab reduced heart attack and strokes by nearly a fourth and cancer by about half.

More than ever, physicians believe that reducing chronic inflammation will also reduce heart attacks and strokes. Robert A. Harrington, M.D., a Cardiologist with the Department of Medicine at Stanford University, leans toward the inflammatory hypothesis of heart disease, a belief that chronic inflammation is a significant cause of heart disease. According to Dr. Harrington.

“Inflammatory cells and signals drive the healing response to vascular injury, allowing the initiation and growth of atherosclerotic plaque.”

Continue reading “Trial Shows Canakinumab Prevents Cancer and Heart Attacks” »